Figure 4
Forest plots depicting the effect of Evelocumab for subgroup analysis after grouping by methods of treatment. (a) on LDL-C; (b) on HDL; (c) on TC; (d) on TG; (e) on Apo-B; (f) on Lp(a); (g) on Apo-A1.
Figure 4 | Scientific Reports
Forest plots depicting the effect of Evelocumab for subgroup analysis after grouping by methods of treatment. (a) on LDL-C; (b) on HDL; (c) on TC; (d) on TG; (e) on Apo-B; (f) on Lp(a); (g) on Apo-A1.
